Pharmaceutical Excipients Market Size, Growth and Trends Analysis by Function (Binder, Lubricant, Filler, Coating), Application (Oral, Parenteral, Topical), Product (Organic Chemicals, Inorganic Chemicals) - Forecast 2030

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technique

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE

6.1. Overview

6.2. Pharmaceutical Fillers

6.3. Binders

6.4. Coatings

6.5. Disintegrants

6.6. Preservatives

6.7. Others

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT

7.1. Overview

7.2. Organic Chemicals

7.3. Inorganic Chemicals

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION

8.1. Overview

8.2. Oral

8.3. Topical

8.4. Parenteral

8.5. Others

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Pharmaceutical Excipients Market

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Pharmaceutical Excipients Market

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Evonik Industries Ag

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Product Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Basf SE

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Product Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Ferro Corporation

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Product Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. P&G Chemicals

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Product Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. FMC Corporation

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Product Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. The Dow Chemical Company

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Product Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Ashland, Inc.

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Product Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Croda International PLC

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Product Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Akzo Nobel NV

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Product Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Innophos

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Product Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SYNOPSIS, 2019–2032

TABLE 2 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 9 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 10 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 11 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 12 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 13 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 14 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 15 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 16 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 17 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019–2032 (USD MILLION)

TABLE 18 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 19 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 20 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 21 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 22 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 23 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 24 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 25 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 26 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 27 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 28 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 29 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 30 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 31 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 32 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 33 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 34 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 35 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 36 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 37 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 38 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 39 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 40 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 41 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 42 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 43 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 44 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 45 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 46 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 47 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 48 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 49 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 50 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 51 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 52 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 53 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 54 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 55 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 56 AUSTRALIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 57 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 58 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 59 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 60 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 61 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 62 REST OF ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 63 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY 2019–2032 (USD MILLION)

TABLE 64 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 65 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 66 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 67 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 68 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 69 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 70 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 71 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 72 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 73 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2019–2032 (USD MILLION)

TABLE 74 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 75 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET

FIGURE 4 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY FUNCTION, 2022

FIGURE 5 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY PRODUCT, 2022

FIGURE 6 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 9 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL EXCIPIENTS MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 12 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS (%), 2022

FIGURE 13 EVONIK INDUSTRIES AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 EVONIK INDUSTRIES AG: SWOT ANALYSIS

FIGURE 15 BASF SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 BASF SE: SWOT ANALYSIS

FIGURE 17 P&G CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 P&G CHEMICALS: SWOT ANALYSIS

FIGURE 19 AKZO NOBEL NV, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 AKZO NOBEL NV, INC: SWOT ANALYSIS

FIGURE 21 FMC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 FMC CORPORATION: SWOT ANALYSIS

FIGURE 23 THE DOW CHEMICAL COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 THE DOW CHEMICAL COMPANY: SWOT ANALYSIS

FIGURE 25 ASHLAND, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ASHLAND, INC.: SWOT ANALYSIS

FIGURE 27 CRODA INTERNATIONAL PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 CRODA INTERNATIONAL PLC: SWOT ANALYSIS

FIGURE 29 FERRO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 FERRO CORPORATION: SWOT ANALYSIS

FIGURE 31 INNOPHOS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 INNOPHOS: SWOT ANALYSIS